Inherited Disease

3

Review clinical trials related to Inherited Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Adaptive Optics Retinal Imaging in Inherited and Acquired Retinal Disorders

This is a Prospective Observational study. The aim of the study is to understand the underlying photoreceptor, retinal pigment epithelium or retinal vascular aberrations in inherited and acquired retinal disorders. The study would use adaptive optics (AO) technology to assist in-vivo visualization of these retinal structures and ascertain changes from normal. Further, by using the AO imaging in patients before and after treatments, this study aims to better understand the effect of various interventions and develop AO as an outcome measure in various retinal disorders.

Participants needed: 200
Trial details
Age: 5-70Biological sex: AllType: ObservationalSponsor: The Hospital for Sick ChildrenUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Consent provided [+5]

Inability of the subject to maintain a stable position while seated [+7]

Status: Recruiting

Blood Markers of Early Pancreas Cancer

Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose a longitudinal study of subjects at higher than average risk of PDAC in order to generate clinical data and bank serial blood specimens.

Participants needed: 1,250
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: University of NebraskaUpdated: Feb 2, 2026Locations: 1
Eligibility criteria

Age ≥19 [+3]

Personal history of pancreatic ductal adenocarcinoma (PDAC) [+2]

Status: Recruiting

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

General aim of the study is the improvement of the clinical knowledge of ultra-rare inherited metabolic and degenerative neurological diseases (prevalence less than 5:100,000) in adulthood through the systematic longitudinal collection of clinical, laboratory and instrumental data.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaUpdated: Nov 19, 2024Locations: 1
Eligibility criteria

Age >= 18 years [+2]

none